IDYA logo

IDEAYA Biosciences, Inc. (IDYA)

Profile

Full Name

IDEAYA Biosciences, Inc.

Ticker

NASDAQ: IDYA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 23, 2019

Indexes

Not included

Website

http://www.ideayabio.com

Employees

131

Key Details

Price

$22.80(-0.74%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$7.00M(-70.07% YoY)

Annual EPS

-$3.36(-71.43% YoY)

PE ratio

-

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $22.80
    IDYA price is $22.80

    30-Day Relative Volume

    0.89
    IDYA 30-day relative volume is 0.89

    Price Performance

    Price Most recent change

    -0.74%
    IDYA price was down -0.74% on Jul 10, 2025

    Price YTD change

    -11.28%
    IDYA price is down -11.28% since January 1st

    Price 1-year change

    -38.91%
    IDYA price is down -38.91% year-on-year

    Price 3-year change

    +47.76%
    IDYA price is up +47.76% over the past 3 years

    Price Range

    Price All-time high

    $47.73
    IDYA price is currently -52.24% below its historical high of $47.73

    Price 3-year low

    $9.00
    IDYA price is currently +153.33% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.00B
    IDYA market capitalization is $2.00 billion

    Market cap 3-year change

    +234.37%
    IDYA market capitalization is up +234.37% over the past 3 years

    Market cap All-time high

    $3.78B
    IDYA market capitalization is currently -47.20% below its historical high of $3.78 billion

    Market cap sector rank

    81.82%
    IDYA market capitalization is higher than 81.82% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +15.1%
    IDYA shares outstanding is up +15.1% year-on-year

    Shares Outstanding 3-Year Change

    +126.29%
    IDYA shares outstanding is up +126.29% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.08
    IDYA beta is 1.08

    200-day SMA

    $23.28
    IDYA price is currently -2.08% below its 200-day simple moving average

    50-day SMA

    $20.46
    IDYA price is currently +11.44% above its 50-day simple moving average

    RSI

    60.63
    IDYA 14-day relative strength index is 60.63

    Volume

    0.89
    IDYA 30-day relative volume is 0.89

    ATR

    $0.94
    IDYA average true range is $0.94

    10-day Historical Volatility

    54.41%
    IDYA 10-day historical volatility is 54.41%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $7.00M
    IDYA annual revenue is $7.00 million

    Revenue Analysts estimate

    $14.64M
    IDYA annual revenue is currently -52.19% lower than the consensus analysts' forecast

    Revenue 1-year change

    -70.07%
    IDYA annual revenue is down -70.07% year-on-year

    Revenue Sector rank

    23.48%
    IDYA annual revenue is higher than 23.48% of companies in Healthcare sector

    EPS

    EPS

    -$3.36
    IDYA annual earnings per share is -$3.36

    EPS Analysts estimate

    -$3.18
    IDYA annual earnings per share is currently +5.51% higher than the consensus analysts' forecast

    EPS 1-year change

    -71.43%
    IDYA annual earnings per share is down -71.43% year-on-year

    EPS Sector rank

    27.16%
    IDYA annual earnings per share is higher than 27.16% of companies in Healthcare sector

    Profit

    Gross profit

    -
    IDYA annual gross profit value is unknown

    Gross margin

    -
    IDYA annual gross profit margin value is unknown

    Operating profit

    -$326.98M
    IDYA annual operating income is -$326.98 million

    Operating margin

    -4671.07%
    IDYA annual operating profit margin is -4671.07%

    Net income

    -$274.48M
    IDYA annual net profit is -$274.48 million

    Net margin

    -3921.10%
    IDYA annual net profit margin is -3921.10%

    Expenses

    Total expenses

    $333.98M
    IDYA annual total expenses is $333.98 million

    Operating expenses

    $333.98M
    IDYA annual total operating expenses is $333.98 million

    Cost of goods sold

    -
    IDYA annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $39.30M
    IDYA annual SGA is $39.30 million

    Depreciation and amortization

    $3.83M
    IDYA annual depreciation & amortization is $3.83 million

    Interest expense

    -
    IDYA annual interest expense value is unknown

    Income tax

    -
    IDYA annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$326.98M
    IDYA annual earnings before interest & taxes is -$326.98 million

    EBITDA

    -$326.98M
    IDYA annual EBITDA is -$326.98 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.12B
    IDYA annual total assets is $1.12 billion

    Non current assets

    $41.94M
    IDYA annual long term assets is $41.94 million

    Current assets

    $1.08B
    IDYA annual total current assets is $1.08 billion

    Cash and cash equivalents

    $84.38M
    IDYA annual cash & cash equivalents is $84.38 million

    Accounts receivable

    $3000.00
    IDYA annual accounts receivable is $3000.00

    Inventory

    -
    IDYA annual inventory value is unknown

    Liabilities

    Total liabilities

    $64.94M
    IDYA annual total liabilities is $64.94 million

    Long term liabilities

    $18.87M
    IDYA annual total long term liabilities is $18.87 million

    Current liabilities

    $46.07M
    IDYA annual total current liabilities is $46.07 million

    Accounts payable

    $15.42M
    IDYA annual accounts payable is $15.42 million

    Debt

    Total debt

    $19.17M
    IDYA annual total debt is $19.17 million

    Total debt 1-year change

    +567.51%
    IDYA annual total debt is up +567.51% year-on-year

    Long term debt

    $18.87M
    IDYA annual long term debt is $18.87 million

    Short term debt

    $298.00K
    IDYA annual short term debt is $298.00 thousand

    Equity & Capital

    Shareholders equity

    $1.06B
    IDYA annual stockholders equity is $1.06 billion

    Book value

    $1.06B
    IDYA annual book value is $1.06 billion

    Retained earnings

    -$622.84M
    IDYA annual retained earnings is -$622.84 million

    Working capital

    $643.64M
    IDYA annual working capital is $643.64 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$247.58M
    IDYA annual cash flow from operations is -$247.58 million

    Cash from operations 1-year change

    -114.87%
    IDYA annual cash flow from operations is down -114.87% year-on-year

    Cash from investing

    -$502.56M
    IDYA annual cash flow from investing activities is -$502.56 million

    Cash from investing 1-year change

    -217.16%
    IDYA annual cash flow from investing activities is down -217.16% year-on-year

    Cash from financing

    $677.55M
    IDYA annual cash flow from financing activities is $677.55 million

    Cash from financing 1-year change

    +86.8%
    IDYA annual cash flow from financing activities is up +86.8% year-on-year

    CAPEX

    CAPEX

    $3.86M
    IDYA annual capital expenditures is $3.86 million

    CAPEX 1-year change

    +62.88%
    IDYA annual capital expenditures is up +62.88% year-on-year

    Free Cash Flow

    Free cash flow

    -$251.44M
    IDYA annual free cash flow is -$251.44 million

    Free cash flow 1-year change

    -113.82%
    IDYA annual free cash flow is down -113.82% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    IDYA annual gross profit margin value is unknown

    Operating margin

    -4671.07%
    IDYA annual operating profit margin is -4671.07%

    Net margin

    -3921.10%
    IDYA annual net profit margin is -3921.10%

    ROA & ROE

    ROA

    -30.95%
    IDYA annual return on assets is -30.95%

    ROE

    -32.67%
    IDYA annual return on equity is -32.67%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    IDYA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    IDYA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.95
    IDYA price to book ratio is 1.95

    PB ratio Sector rank

    55.33%
    IDYA price to book ratio is higher than 55.33% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    IDYA price to sales ratio value is unknown

    PS ratio Sector rank

    -
    IDYA price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $1.89B
    IDYA enterprise value is $1.89 billion

    Enterprise value Sector rank

    79.75%
    IDYA enterprise value is higher than 79.75% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -5.31
    IDYA EV/EBITDA is -5.31

    EV/EBITDA Sector rank

    22.87%
    IDYA EV/EBITDA is higher than 22.87% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    14.97
    IDYA annual current ratio is 14.97

    Quick ratio

    -
    IDYA annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    IDYA annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    IDYA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    IDYA piotroski f-score value is unknown

    Altman Z-Score

    17.41
    IDYA altman z-score is 17.41

    Analyst ratings

    Recent major analysts updates

    Jun 26, 25 Wells Fargo
    Overweight
    May 22, 25 JP Morgan
    Overweight
    Feb 14, 25 Stephens & Co.
    Overweight
    Jan 15, 25 RBC Capital
    Outperform
    Jan 13, 25 Cantor Fitzgerald
    Overweight
    Dec 17, 24 Wedbush
    Outperform
    Dec 17, 24 Cantor Fitzgerald
    Overweight
    Nov 18, 24 Stephens & Co.
    Overweight
    Nov 5, 24 Leerink Partners
    Market Perform
    Oct 29, 24 Oppenheimer
    Outperform

    Institutional Ownership

    Screeners with IDYA included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    • What is the ticker symbol for IDEAYA Biosciences, Inc.?
    • Does IDEAYA Biosciences, Inc. pay dividends?
    • What sector is IDEAYA Biosciences, Inc. in?
    • What industry is IDEAYA Biosciences, Inc. in?
    • What country is IDEAYA Biosciences, Inc. based in?
    • When did IDEAYA Biosciences, Inc. go public?
    • Is IDEAYA Biosciences, Inc. in the S&P 500?
    • Is IDEAYA Biosciences, Inc. in the NASDAQ 100?
    • Is IDEAYA Biosciences, Inc. in the Dow Jones?
    • When was IDEAYA Biosciences, Inc.'s last earnings report?
    • When does IDEAYA Biosciences, Inc. report earnings?

    What is the ticker symbol for IDEAYA Biosciences, Inc.?

    The ticker symbol for IDEAYA Biosciences, Inc. is NASDAQ:IDYA

    Does IDEAYA Biosciences, Inc. pay dividends?

    No, IDEAYA Biosciences, Inc. does not pay dividends

    What sector is IDEAYA Biosciences, Inc. in?

    IDEAYA Biosciences, Inc. is in the Healthcare sector

    What industry is IDEAYA Biosciences, Inc. in?

    IDEAYA Biosciences, Inc. is in the Biotechnology industry

    What country is IDEAYA Biosciences, Inc. based in?

    IDEAYA Biosciences, Inc. is headquartered in United States

    When did IDEAYA Biosciences, Inc. go public?

    IDEAYA Biosciences, Inc.'s initial public offering (IPO) was on May 23, 2019

    Is IDEAYA Biosciences, Inc. in the S&P 500?

    No, IDEAYA Biosciences, Inc. is not included in the S&P 500 index

    Is IDEAYA Biosciences, Inc. in the NASDAQ 100?

    No, IDEAYA Biosciences, Inc. is not included in the NASDAQ 100 index

    Is IDEAYA Biosciences, Inc. in the Dow Jones?

    No, IDEAYA Biosciences, Inc. is not included in the Dow Jones index

    When was IDEAYA Biosciences, Inc.'s last earnings report?

    IDEAYA Biosciences, Inc.'s most recent earnings report was on May 6, 2025

    When does IDEAYA Biosciences, Inc. report earnings?

    The next expected earnings date for IDEAYA Biosciences, Inc. is August 6, 2025
    On this page